New
Radiation Oncology Market Research Report by Type (Brachytherapy, External Beam Radiation Therapy, and Radioisotope Therapy), Application, Country - Cumulative Impact of COVID-19, Russia Ukraine Confl…
New
Radiation Oncology Market Research Report by Type (Brachytherapy, External Beam Radiation Therapy, and Radioisotope Therapy), Application, State - Cumulative Impact of COVID-19, Russia Ukraine Conflic…
New
Radiotherapy Market Research Report by Product (Conventional Cobalt-60 Teletherapy Units, Conventional Linear Accelerators, and Electron-Emitting High-Energy Linear Accelerators), Procedure, Applicati…
New
Radiotherapy Market Research Report by Product (Conventional Cobalt-60 Teletherapy Units, Conventional Linear Accelerators, and Electron-Emitting High-Energy Linear Accelerators), Procedure, Applicati…
New
U.S. Prostate Cancer Testing Market to Reach $1,901.6 Million by 2030 U.S. Prostate Cancer Testing Market Industry Overview The U.S. prostate cancer testing market is anticipated to reach $1,901.6 m…
Abstract: What`s New for 2022? Global competitiveness and key competitor percentage market shares Market presence across multiple geographies - Strong/Active/Niche/Trivial Online interactive peer-to-…
Abstract: What’s New for 2022? Global competitiveness and key competitor percentage market shares Market presence across multiple geographies - Strong/Active/Niche/Trivial Online interactive peer-to…
Interventional Oncology (IO) is a rapidly growing field in cancer care that uses minimally invasive procedures performed under image guidance to diagnose and treat patients with liver, kidney, lung, B…
The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased fundi…
Major players in the prostate cancer drugs market are Astellas Inc., AstraZeneca plc, Johnson & Johnson, Sanofi S.A, Bayer AG, Roche, Abbott, Pfizer, Norvaris and F. Hoffmann-La Roche AG. The global …
Major players in the prostate cancer drugs market are Astellas Inc., AstraZeneca plc, Johnson & Johnson, Sanofi S.A, and Bayer AG. The global prostate cancer drugs market is expected to grow from $3.…
The Global Castrate-resistant Prostate Cancer Market size is expected to reach $14.5 billion by 2026, rising at a market growth of 8.3% CAGR during the forecast period. Castrate-resistant Prostate Can…
The North America Flavonoids Market would witness market growth of 11.5% CAGR during the forecast period (2022-2028). It is histamine blocker that reduces inflammation brought on by arthritis, heart …
The North America Proton Therapy Market would witness market growth of 11.8% CAGR during the forecast period (2022-2028). Proton therapy (PT) is being quickly adopted by the oncology field to enhance…
The North America Radiotherapy Market would witness market growth of 5.6% CAGR during the forecast period (2022-2028). Radiation therapy could be the only option for some patients. However, radiation…
The North America Castrate-resistant Prostate Cancer Market would witness market growth of 7.5% CAGR during the forecast period (2020-2026). The cases of Castrate-resistant prostate cancer are increa…
New
Summary iCAD Inc (iCAD) is a medical technology company that provides advanced image analysis, radiation therapies and workflow solutions for the early disclosure and treatment of cancers. The company…
New
Summary Clinical Laserthermia Systems AB (CLS) is a medical equipment company that develops and markets instruments for the treatment of cancer.The company offers Tranberg, a thermal therapy system de…
Summary Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the development of tests for various types of cancers.The company’s flagship product, Cologuard test is a…
Summary Precision Biologics Inc (PBI), a subsidiary of NantWorks LLC, is a clinical-stage biotechnology company.The company offers cancer vaccines, antigens and antibodies, pipelines, diagnostics, the…
Summary MDxHealth SA (MDxHealth) develops and commercializes advanced epigenetic and other molecular tests for cancer assessment, and the personalized treatment of patients.The company’s products port…
Overview A US-based key opinion leader (KOL) provides insights into prescribing habits, key marketed brands, and late-phase pipeline therapies for prostate cancer. Key pipeline assets highlighted inc…
Overview A US-based key opinion leader (KOL) provides insights into prescribing habits, key marketed brands, and late-phase pipeline therapies for prostate cancer. Key pipeline assets highlighted inc…
Latest key takeaways The analyst estimates that in 2018, there were 1.3 million incident cases of prostate cancer worldwide in males aged 40 years and older, and forecasts that number to increase …
